Ernestien Jensema, Martin Jelsma, Tom Kramer, Tom Blickman
01 ဇွန်လ 2014
TNI's indepth examination of the illegal drug market in the Golden Triangle, which has witnessed a doubling of opium production, growing prison populations and repression of small-scale farmers. This report details the failure of ASEAN's 'drug free' strategy and the need for a new approach.
This policy briefing analyses the results of the partial agreement on drugs reached at the talks being held in Havana between the Revolutionary Armed Forces of Colombia, FARC, and the Colombian government.
The eleventh Informal Drug Policy Dialogue took place in Athens. Topics amongst others were the national drug policy and drug situation in Greece, current affairs in Vienna, global cannabis policy developments and the upcoming UN General Assembly Special Session on Drugs in 2016.
Cannabis was condemned by the 1961 Single Convention on Narcotic Drugs as a psychoactive drug with “particularly dangerous properties” and hardly any therapeutic value. Ever since, an increasing number of countries have shown discomfort with the treaty regime’s strictures through soft defections, stretching its legal flexibility to sometimes questionable limits.
How does national legislation in different EU member states compare and how effective is the adding of new psychoactive substances (NPS) to the existing schedules of drug laws versus legislative experimentation designing new schedules or applying controls under medicines or consumer protection regulations?
Despite efforts by governments in Latin America, illicit drugs continue to provide one of the largest incomes for criminal organizations, enabling them to penetrate and corrupt political and social institutions.
Many myths surround coca. Every day press accounts around the world use the word coca in their headlines, when in fact they refer to cocaine. TNI's Drugs and Democracy Team exposes the myths and reality surrounding the coca leaf.
American attitudes toward marijuana policy are shifting. Recent polls suggest that the majority of Americans think marijuana use should be legalized. How might a shift in American marijuana policies affect the prohibitionist drug treaty system?
The International Narcotics Control Board (INCB) has called changes to cannabis laws in Uruguay and the US a ‘very grave danger to public health’, but campaigners for reform to drugs laws say the INCB’s comments are ‘shortsighted and narrow minded.’
The global drug prohibition bureaucracy's watchdog group, the International Drug Control Board (INCB) released its Annual Report 2013 today, voicing its concerns with and wagging its finger at drug reform efforts that deviate from its interpretation of the international drug control treaties that birthed it. The INCB is "concerned" about moves toward marijuana legalization and warns about "the importance of universal implementation of international drug control treaties by all states."
State-level cannabis reforms have exposed the inability of the United States to abide by the terms of the legal bedrock of the global drug control system. It is calls for a conversation the US federal government wishes to avoid. The result is a new official position on the UN drugs treaties that, despite its seductively progressive tone, serves only to sustain the status quo and may cause damage beyond drug policy.
Misunderstandings and misreporting of actual and proposed changes to Dutch cannabis policy in 2011 have led some opponents of cannabis reform to suggest the country is retreating from its longstanding and pragmatic policy of tolerating the possession, use and sale of cannabis. This is not the case. In reality, most of the more regressive measures have either not been implemented, have been subsequently abandoned, or have had only marginal impacts.
In March 2014, country delegations will gather at the United Nations Commission on Narcotic Drugs (CND) to review progress and challenges in international drug control since the agreement of a Political Declaration on drugs in 2009. Given that the Political Declaration aims to “eliminate or reduce significantly” the use, supply and demand of controlled drugs by 2019, this meeting represents an important opportunity for honest evaluation and an acknowledgement that these targets are not being achieved. With a United Nations General Assembly Special Session (UNGASS) on drugs just two years away, this is an important time for international drug control policy.
The upcoming United Nations General Assembly Special Session on Drugs (UNGASS) in 2016 is an unprecedented opportunity to review and re-direct national drug control policies and the future of the global drug control regime. As diplomats sit down to rethink international and domestic drug policy, they would do well to recall the mandate of the United Nations, not least to ensure security, human rights and development.